Table 4 Comparisons of complications or adverse events in the two groups [n(%)]
Parameters | TURP group (320) | PKEP group (530) | x2 | P |
|---|---|---|---|---|
Massive blood loss (> 600 mL) | 15(4.69) | 9(1.70) | 6.499 | 0.011 |
Postoperative secondary bleeding | 21(6.56) | 7(1.32) | 17.209 |  < 0.001 |
Blood transfusion | 14(4.38) | 6(1.13) | 9.133 | 0.003 |
Capsular perforation | 6(1.88) | 2(0.75) | 4.800 | 0.028 |
Bladder injury | 1(0.43) | 0(0.00) | – | 0.798 |
Urinary tract irritation | 109(34.06) | 117(22.08) | 14.688 |  < 0.001 |
Bladder spasm | 32(10.00) | 29(5.47) | 6.142 | 0.013 |
Clot retention | 13(4.06) | 4(0.75) | 11.138 | 0.001 |
Acute epididymitis | 3(0.94) | 4(0.75) | 0.011 | 0.916 |
Urinary tract infection | 10(3.13) | 6(1.13) | 4.291 | 0.038 |
Shock | 4(1.25) | 2(0.38) | 1.102 | 0.294 |
Transurethral resection syndrome | 1(0.43) | 0(0.00) | – | 0.129 |
Transient incontinence | 17(5.31) | 12(2.26) | 5.626 | 0.018 |
Permanent incontinence | 0(0.00) | 2(0.38) | – | 0.351 |
Urethral stricture | 8(2.50) | 6(1.13) | 2.305 | 0.129 |
Erectile dysfunction # | 84(26.25) | 96(18.11) | 7.914 | 0.005 |
Retrograde ejaculation # | 119(37.19) | 167(31.51) | 2.881 | 0.090 |
Recurrence | 3(0.94) | 2(0.38) | 0.327 | 0.567 |
Clavien–Dindo Classification △ | ||||
I | 164(51.25%) | 243(45.85%) | 2.332 | 0.127 |
II | 83(25.94%) | 87(16.42%) | 11.308 | 0.001 |
III | 19(5.94%) | 13(2.45%) | 6.688 | 0.010 |
IV | 5(1.56%) | 3(0.57%) | 2.125 | 0.145 |
V | 1(0.31%) | 0(0.00%) | – | 0.798 |